AFT Pharmaceuticals targets multi-billion-dollar markets with pipeline products
The pharmaceutical company says it has eight patented projects and 24 off-patent injectables in development or commercialisation.
AFT Pharmaceuticals is positioning itself for expansion into major markets through its range of products at various development stages. The company's portfolio includes eight patented projects, 24 off-patent injectables, and other projects in early commercialisation phases.
Covered byRNZNot covered byStuffNZ Herald1NewsNewstalk ZBOtago Daily TimesNewsroomThe SpinoffBusinessDeskinterest.co.nz
Coverage across the news outlets we track, as at publication.
What outlets are saying
RNZ
AFT Pharmaceuticals eyes 'multi-billion-dollar markets' for products still in development
The company says it has eight patented projects, 24 off-patent injectables and other projects in the early stages of commercialisation.